Woodward WR - Search Results

1

The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses.

Woodward WR, Olanow CW, Beckner RM, Hauser RA, Gauger LL, Cedarbaum JM, Nutt JG. Woodward WR, et al. Neurology. 1993 Sep;43(9):1704-8. doi: 10.1212/wnl.43.9.1704. Neurology. 1993. PMID: 8414016

2

The effect of exercise on levodopa absorption.

Carter JH, Nutt JG, Woodward WR. Carter JH, et al. Among authors: woodward wr. Neurology. 1992 Oct;42(10):2042-5. doi: 10.1212/wnl.42.10.2042. Neurology. 1992. PMID: 1407589

3

Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients.

Irwin RP, Nutt JG, Woodward WR, Gancher ST. Irwin RP, et al. Among authors: woodward wr. Clin Neuropharmacol. 1992 Oct;15(5):365-74. doi: 10.1097/00002826-199210000-00003. Clin Neuropharmacol. 1992. PMID: 1423336 Clinical Trial.

4

Time course of tolerance to apomorphine in parkinsonism.

Gancher ST, Nutt JG, Woodward WR. Gancher ST, et al. Among authors: woodward wr. Clin Pharmacol Ther. 1992 Nov;52(5):504-10. doi: 10.1038/clpt.1992.178. Clin Pharmacol Ther. 1992. PMID: 1424425

5

Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon.

Nutt JG, Woodward WR, Carter JH, Gancher ST. Nutt JG, et al. Among authors: woodward wr. Arch Neurol. 1992 Nov;49(11):1123-30. doi: 10.1001/archneur.1992.00530350037016. Arch Neurol. 1992. PMID: 1444877

6

Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's disease.

Grandas F, Gancher S, Lera G, Rodriguez M, Woodward WR, Nutt J, Obeso JA. Grandas F, et al. Among authors: woodward wr. Neurology. 1992 Jul;42(7):1287-90. doi: 10.1212/wnl.42.7.1287. Neurology. 1992. PMID: 1620335

7

Absorption of apomorphine by various routes in parkinsonism.

Gancher ST, Nutt JG, Woodward WR. Gancher ST, et al. Among authors: woodward wr. Mov Disord. 1991;6(3):212-6. doi: 10.1002/mds.870060304. Mov Disord. 1991. PMID: 1922125

8

L-dopa pharmacokinetics in plasma and cisternal and lumbar cerebrospinal fluid of monkeys.

Hammerstad JP, Woodward WR, Gliessman P, Boucher B, Nutt JG. Hammerstad JP, et al. Among authors: woodward wr. Ann Neurol. 1990 May;27(5):495-9. doi: 10.1002/ana.410270507. Ann Neurol. 1990. PMID: 2360790

9

The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.

Gancher ST, Woodward WR, Gliessman P, Boucher B, Nutt JG. Gancher ST, et al. Among authors: woodward wr. Ann Neurol. 1990 Jun;27(6):660-5. doi: 10.1002/ana.410270613. Ann Neurol. 1990. PMID: 2360803

10

Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease.

Carter JH, Nutt JG, Woodward WR, Hatcher LF, Trotman TL. Carter JH, et al. Among authors: woodward wr. Neurology. 1989 Apr;39(4):552-6. doi: 10.1212/wnl.39.4.552. Neurology. 1989. PMID: 2648188 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters